TCL Archive ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies June 5, 2009
TCL Archive SBIR: A Sure Fire Way to Get Funded In A Year When Applications Scoring Over 158 Are Being Dropped February 22, 1985
TCL Archive Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study May 30, 2008